CP
Therapeutic Areas
NeuroEM Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MemorEM | Alzheimer's Disease | Phase 2 |
Leadership Team at NeuroEM Therapeutics
WS
William Scott Burgin, MD
Chief Medical Officer
EG
Edward Goodwin, PhD
Chief Science Officer
CC
Chuanhai Cao, PhD
Head of USF Research Team
TI
Tracy Ingram
Chief Operating & Information Officer
MT
Marilyn Thompson
Chief Financial Officer
GA
Gary Arendash, PhD
Founder & Scientist Emeritus